Literature DB >> 22547423

Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.

Nicola Napoli1, Jenny Jin, Katherine Peters, Rosanna Wustrack, Shane Burch, Aldric Chau, Jane Cauley, Kristine Ensrud, Michael Kelly, Dennis M Black.   

Abstract

CONTEXT: Femoral shaft cortical thickening has been mentioned in reports of atypical subtrochanteric and diaphyseal (S/D) femur fractures, but it is unclear whether thickening precedes fracture or results from a preceding stress fracture and what role bisphosphonates might play in cortical thickening.
OBJECTIVE: Our objective was to examine the relationship of cortical thickness to S/D fracture risk as well as establish normal reference values for femoral cortical thickness in a large population-based cohort of older women.
DESIGN: Using pelvic radiographs obtained in 1986-1988, we measured femoral shaft cortical thickness 3 cm below the lesser trochanter in women in the Study of Osteoporotic Fractures. We measured this in a random sample and in those with S/D fractures and femoral neck and intertrochanteric fractures. Low-energy S/D fractures were identified from review of radiographic reports obtained between 1986 and 2010. Radiographs to evaluate atypia were not available. Analysis used case-cohort, proportional hazards models. OUTCOMES: Cortical thickness as a risk factor for low-energy S/D femur fractures as well as femoral neck and intertrochanteric fractures in the Study of Osteoporotic Fractures, adjusting for age and bone mineral density in proportional hazards models.
RESULTS: After age adjustment, women with thinner medial cortices were at a higher risk of S/D femur fracture, with a relative hazard of 3.94 (95% confidence interval = 1.23-12.6) in the lowest vs. highest quartile. Similar hazard ratios were seen for femoral neck and intertrochanteric fractures. Medial or total cortical thickness was more strongly related to fracture risk than lateral cortical thickness.
CONCLUSIONS: In primarily bisphosphonate-naive women, we found no evidence that thick femoral cortices placed women at higher risk for low-energy S/D femur fractures; in fact, the opposite was true. Women with thin cortices were also at a higher risk for femoral neck and intertrochanteric fractures. Whether cortical thickness among bisphosphonate users plays a role in atypical S/D fractures remains to be determined.

Entities:  

Mesh:

Year:  2012        PMID: 22547423      PMCID: PMC3387394          DOI: 10.1210/jc.2011-3256

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Authors:  Dennis M Black; Michael P Kelly; Harry K Genant; Lisa Palermo; Richard Eastell; Christina Bucci-Rechtweg; Jane Cauley; Ping Chung Leung; Steven Boonen; Arthur Santora; Anne de Papp; Douglas C Bauer
Journal:  N Engl J Med       Date:  2010-03-24       Impact factor: 91.245

2.  Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.

Authors:  Laura Y Park-Wyllie; Muhammad M Mamdani; David N Juurlink; Gillian A Hawker; Nadia Gunraj; Peter C Austin; Daniel B Whelan; Peter J Weiler; Andreas Laupacis
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

3.  Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.

Authors:  Bo Abrahamsen; Pia Eiken; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

4.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

Review 5.  Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies.

Authors:  Andrea Giusti; Neveen A T Hamdy; Socrates E Papapoulos
Journal:  Bone       Date:  2010-05-20       Impact factor: 4.398

6.  Fragility fractures of the hip and femur: incidence and patient characteristics.

Authors:  J W Nieves; J P Bilezikian; J M Lane; T A Einhorn; Y Wang; M Steinbuch; F Cosman
Journal:  Osteoporos Int       Date:  2009-05-30       Impact factor: 4.507

7.  Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study.

Authors:  Bo Abrahamsen; Pia Eiken; Richard Eastell
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

8.  Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

Authors:  B A Lenart; A S Neviaser; S Lyman; C C Chang; F Edobor-Osula; B Steele; M C H van der Meulen; D G Lorich; J M Lane
Journal:  Osteoporos Int       Date:  2008-12-09       Impact factor: 4.507

9.  Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?

Authors:  Joyce S B Koh; Seo Kiat Goh; Meng Ai Png; Ernest B K Kwek; Tet Sen Howe
Journal:  J Orthop Trauma       Date:  2010-02       Impact factor: 2.512

Review 10.  Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

Authors:  R Rizzoli; K Akesson; M Bouxsein; J A Kanis; N Napoli; S Papapoulos; J-Y Reginster; C Cooper
Journal:  Osteoporos Int       Date:  2010-11-18       Impact factor: 4.507

View more
  7 in total

1.  Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.

Authors:  J H Koh; J P Myong; J Yoo; Y-W Lim; J Lee; S-K Kwok; S-H Park; J H Ju
Journal:  Osteoporos Int       Date:  2017-07-27       Impact factor: 4.507

2.  Atypical fractures do not have a thicker cortex.

Authors:  V A Koeppen; J Schilcher; P Aspenberg
Journal:  Osteoporos Int       Date:  2012-10-18       Impact factor: 4.507

3.  Increased risk of intraoperative and early postoperative periprosthetic femoral fracture with uncemented stems.

Authors:  Martin Lindberg-Larsen; Christoffer C Jørgensen; Søren Solgaard; Anne G Kjersgaard; Henrik Kehlet
Journal:  Acta Orthop       Date:  2017-03-14       Impact factor: 3.717

4.  Atypical Femoral Shaft Fractures in Female Bisphosphonate Users Were Associated with an Increased Anterolateral Femoral Bow and a Thicker Lateral Cortex: A Case-Control Study.

Authors:  Seung Pil Jang; Ingwon Yeo; Sang-Yeon So; Keunbyuel Kim; Young-Wan Moon; Youn-Soo Park; Seung-Jae Lim
Journal:  Biomed Res Int       Date:  2017-03-28       Impact factor: 3.411

5.  [The measurement and clinical significance of the rotation angles of head-neck fragments after cephalomedullary nail fixation in intertrochanteric fractures].

Authors:  Shouchao Du; Wenfeng Xiong; Shimin Zhang; Sunjun Hu; Lizhi Zhang; Shiyi Chen; Zhen Wei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-10-15

6.  Risk factors for intraoperative calcar fracture in cementless total hip arthroplasty.

Authors:  Simo S A Miettinen; Tatu J Mäkinen; Inari Kostensalo; Keijo Mäkelä; Heini Huhtala; Jukka S Kettunen; Ville Remes
Journal:  Acta Orthop       Date:  2015-11-06       Impact factor: 3.717

7.  Difference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents.

Authors:  Sungjun Kim; Hyun Hee Bang; Hanna Yoo; Il Hyung Park; Kyu Hyun Yang; Hyunsun Lim; Woo Seok Jung
Journal:  J Bone Metab       Date:  2016-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.